Your browser doesn't support javascript.
Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014.
Severi, Ettore; Georgalis, Leonidas; Pijnacker, Roan; Veneti, Lamprini; Turiac, Iulia Adelina; Chiesa, Flaminia; Rizzo, Caterina; Martinelli, Domenico; Vold, Line; Herrador, Bernardo Guzman; Martinez, Carmen Varela; Sanchez, Elena Vanessa Martinez; Semenza, Jan C; Lopalco, Pierluigi; Dahlström, Lisen Arnheim; Giesecke, Johan.
  • Severi E; European Centre for Disease Prevention and Control, Stockholm, Sweden; Karolinska Institutet, Medical Epidemiology and Biostatistics Department, Stockholm, Sweden.
  • Georgalis L; European Programme for Intervention Epidemiology Training (EPIET), ECDC, Stockholm, Sweden; Instituto de Salud Carlos III, CIBER Epidemiologia y Salud Publica, Madrid, Spain.
  • Pijnacker R; European Programme for Intervention Epidemiology Training (EPIET), ECDC, Stockholm, Sweden; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Veneti L; European Programme for Intervention Epidemiology Training (EPIET), ECDC, Stockholm, Sweden; Norwegian Institute of Public Health (NIPH), Oslo, Norway. Electronic address: Lamprini.Veneti@fhi.no.
  • Turiac IA; European Programme for Intervention Epidemiology Training (EPIET), ECDC, Stockholm, Sweden; Università degli studi di Foggia, Foggia, Italy.
  • Chiesa F; Karolinska Institutet, Medical Epidemiology and Biostatistics Department, Stockholm, Sweden.
  • Rizzo C; Bambino Gesù Children's Hospital, Rome, Italy.
  • Martinelli D; Università degli studi di Foggia, Foggia, Italy.
  • Vold L; Norwegian Institute of Public Health (NIPH), Oslo, Norway.
  • Herrador BG; Norwegian Institute of Public Health (NIPH), Oslo, Norway.
  • Martinez CV; Instituto de Salud Carlos III, CIBER Epidemiologia y Salud Publica, Madrid, Spain.
  • Sanchez EVM; Instituto de Salud Carlos III, CIBER Epidemiologia y Salud Publica, Madrid, Spain.
  • Semenza JC; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Lopalco P; Università di Pisa, Pisa, Italy.
  • Dahlström LA; Karolinska Institutet, Medical Epidemiology and Biostatistics Department, Stockholm, Sweden.
  • Giesecke J; Karolinska Institutet, Medical Epidemiology and Biostatistics Department, Stockholm, Sweden.
Int J Infect Dis ; 118: 34-43, 2022 May.
Artículo en Inglés | MEDLINE | ID: covidwho-1838841
ABSTRACT

OBJECTIVES:

We analysed hepatitis A (HepA) notifications and hospitalisations in Italy, the Netherlands, Norway, Spain, and Sweden for available periods between 1995 and 2014. We aimed to investigate whether decreasing HepA incidence is associated with increasing age at infection and worsening HepA presentation and to identify groups at risk of severe disease.

METHODS:

We performed a retrospective cohort study including 36 734 notified and 36 849 hospitalised patients. We used negative binomial regressions to identify over time i) trends in hospitalisation and notification rates; ii) proportion of hospitalised and notified patients aged ≥40 years; iii) proportion of "severe hospitalisations"; and iv) risk factors for severe hospitalisation.

RESULTS:

During the study period both HepA notifications and hospitalisations decreased, with notification rates decreasing faster, patients aged ≥40 years increased, however, the proportion of severe HepA hospitalisations remained stable. Older patients and patients with comorbidities, particularly liver diseases, were more likely to experience severe disease.

CONCLUSIONS:

We used digitalised health information to confirm decreasing trends in HepA hospitalisations and notifications, and the increasing age of patients with HepA in Europe. We did not identify an increase in the severity of the clinical presentation of patients with HepA. Older patients with liver diseases are at increased risk of severe disease and should be prioritised for vaccination.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Hepatitis A Tipo de estudio: Estudio de cohorte / Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos País/Región como asunto: Europa Idioma: Inglés Revista: Int J Infect Dis Asunto de la revista: Enfermedades Transmisibles Año: 2022 Tipo del documento: Artículo País de afiliación: J.ijid.2022.01.053

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Hepatitis A Tipo de estudio: Estudio de cohorte / Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos País/Región como asunto: Europa Idioma: Inglés Revista: Int J Infect Dis Asunto de la revista: Enfermedades Transmisibles Año: 2022 Tipo del documento: Artículo País de afiliación: J.ijid.2022.01.053